Global Dialysis Perspective: Japan.
作者信息
Hanafusa Norio, Fukagawa Masafumi
机构信息
Department of Blood Purification, Tokyo Women's Medical University, Tokyo, Japan.
Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.
出版信息
Kidney360. 2020 Apr 16;1(5):416-419. doi: 10.34067/KID.0000162020. eCollection 2020 May 28.
Abstract
摘要
相似文献
1
Global Dialysis Perspective: Japan.
Kidney360. 2020 Apr 16;1(5):416-419. doi: 10.34067/KID.0000162020. eCollection 2020 May 28.
2
Global Dialysis Perspective: Spain.
Kidney360. 2020 Dec 30;2(2):344-349. doi: 10.34067/KID.0005722020. eCollection 2021 Feb 25.
3
An overview of regular dialysis treatment in Japan (as of 31 December 2012).
Ther Apher Dial. 2014 Dec;18(6):535-602. doi: 10.1111/1744-9987.12281.
4
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013).
Ther Apher Dial. 2015 Dec;19(6):540-74. doi: 10.1111/1744-9987.12378.
5
A Clinical Significance of Intermittent Infusion Hemodiafiltration Using Backfiltration of Ultrapure Dialysis Fluid Compared to Hemodialysis: A Multicenter Randomized Controlled Crossover Trial.
Blood Purif. 2019;48(4):368-381. doi: 10.1159/000501511. Epub 2019 Jul 16.
6
Methods We Currently Use for Home Hemodialysis Management.
Contrib Nephrol. 2018;196:237-242. doi: 10.1159/000485728. Epub 2018 Jul 24.
7
Vascular access for long-term hemodialysis/hemodiafiltration patients in Japan.
Contrib Nephrol. 2015;185:132-7. doi: 10.1159/000380977. Epub 2015 May 19.
8
[Peritoneal dialysis for acute renal failure: Rediscovery of an old modality of renal replacement therapy].
Nephrol Ther. 2016 Jul;12(4):193-7. doi: 10.1016/j.nephro.2016.01.016. Epub 2016 Jun 16.
9
Clinical evaluation indices for hemodialysis/hemodiafiltration in Japan.
Contrib Nephrol. 2011;168:173-178. doi: 10.1159/000321758. Epub 2010 Oct 7.
10
Renal Replacement Therapy in Slovenia: Excerpts From 2013 Data.
Ther Apher Dial. 2016 Jun;20(3):223-8. doi: 10.1111/1744-9987.12427.
引用本文的文献
1
Self-management interventions for adult haemodialysis patients: a scoping review of randomized controlled trials.
BMC Nephrol. 2025 Jun 13;26(1):285. doi: 10.1186/s12882-025-04229-6.
2
First-time diagnosis and referral practices for individuals with CKD by primary care physicians: a study of electronic medical records across multiple clinics in Japan.
Clin Exp Nephrol. 2025 May 16. doi: 10.1007/s10157-025-02695-8.
3
Cost-Effectiveness Analysis of SGLT2 Inhibitors for Cardio-Renal-Metabolic Disease Based on Data from Japanese Studies.
Adv Ther. 2025 Jun;42(6):2888-2905. doi: 10.1007/s12325-025-03157-z. Epub 2025 Apr 29.
4
Chronic Kidney Disease Requiring Hemodialysis as a Significant Predictor of Target Lesion Revascularization After Endovascular Treatment of Femoropopliteal Occlusive Lesions with a Drug-Coated Balloon.
J Clin Med. 2025 Feb 22;14(5):1474. doi: 10.3390/jcm14051474.
5
One-year Survival of End-Stage Kidney Disease Patients Undergoing Hemodialysis in Indonesia.
Int J Nephrol Renovasc Dis. 2025 Mar 12;18:87-101. doi: 10.2147/IJNRD.S508012. eCollection 2025.
6
Cancer diagnosis and prognosis after initiation of hemodialysis: multicenter Japan CANcer and DialYsis (J-CANDY) study.
Clin Kidney J. 2024 Dec 20;18(2):sfae430. doi: 10.1093/ckj/sfae430. eCollection 2025 Feb.
7
Development, Translation, and Validation of the Japanese Quality of Dying and Death Questionnaire for Families of ICU Patients.
Cureus. 2025 Jan 8;17(1):e77161. doi: 10.7759/cureus.77161. eCollection 2025 Jan.
8
Sociodemographic and Economic Correlates of Dialysis Vintage in a Resource Challenged Setting: A Four-Year Prospective Study in Southwest Nigeria.
Niger Med J. 2025 Jan 10;65(6):925-933. doi: 10.60787/nmj.v65i6.532. eCollection 2024 Nov-Dec.
9
Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan.
Adv Ther. 2024 Mar;41(3):1151-1167. doi: 10.1007/s12325-023-02773-x. Epub 2024 Jan 19.
10
The Etiology of Kidney Failure in Indonesia: A Multicenter Study in Tertiary-Care Centers in Jakarta.
Ann Glob Health. 2023 Jun 1;89(1):36. doi: 10.5334/aogh.4071. eCollection 2023.
本文引用的文献
1
2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report.
Kidney Int Rep. 2019 Sep 23;4(11):1523-1537. doi: 10.1016/j.ekir.2019.09.007. eCollection 2019 Nov.
2
Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
BMC Nephrol. 2018 Oct 5;19(1):253. doi: 10.1186/s12882-018-1056-5.
3
Missed Hemodialysis Treatments: International Variation, Predictors, and Outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Am J Kidney Dis. 2018 Nov;72(5):634-643. doi: 10.1053/j.ajkd.2018.04.019. Epub 2018 Aug 23.
4
Association between serum ferritin and mortality: findings from the USA, Japan and European Dialysis Outcomes and Practice Patterns Study.
Nephrol Dial Transplant. 2018 Dec 1;33(12):2234-2244. doi: 10.1093/ndt/gfy190.
5
Associations of frequency and duration of patient-doctor contact in hemodialysis facilities with mortality.
J Am Soc Nephrol. 2013 Sep;24(9):1493-502. doi: 10.1681/ASN.2012080831. Epub 2013 Jul 25.
6
Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.
Ther Apher Dial. 2013 Jun;17(3):247-88. doi: 10.1111/1744-9987.12058.
7
Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant.
Clin J Am Soc Nephrol. 2009 Jul;4(7):1239-45. doi: 10.2215/CJN.01280209. Epub 2009 Jun 18.
8
Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
J Am Soc Nephrol. 2003 Dec;14(12):3270-7. doi: 10.1097/01.asn.0000100127.54107.57.
Zotero 插件